Navigation Links
ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
Date:3/6/2008

- Update on Clinical Developments

MONTREAL, March 6 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX: PLI) ("ProMetic") announces favorable top-line findings from the third cohort in its Phase II trial with PBI-1402 in patients with chemotherapy-induced anemia ("CIA"). Analysis of the compiled data from a total of 18 patients showed an overall statistically significant increase of the mean hematocrit values at weeks 4, 6 and 8, and of the hemoglobin values at week 8. At week 8, p values were 0.02 for hematocrit and hemoglobin. More detailed results from the study have been submitted to the European Hematology Association for presentation at their June 2008 meeting in Copenhagen.

"These results are very encouraging and continue to demonstrate the efficacy and safety profile of PBI-1402, a non-EPO (erythropoietin) treatment for CIA," states Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic Life Sciences Inc. "We are excited about the prospects for PBI-1402 for the treatment of anemia in oncology since, unlike EPO, PBI-1402 demonstrated some anticancer activity in animal models. We look forward to sharing more detailed clinical trial results."

Other PBI-1402 development highlights include the extension of the enrollment for the PBI-1402 CIA trial to include an additional 12 patients receiving the lowest trial dose. Data from these additional patients are expected by June 2008.

In addition, a new Phase II study in patients with anemia resulting from chronic kidney disease has been scheduled. This multi-center study will be placebo controlled and will examine the effect of PBI-1402 on anemia, as well as several other clinical parameters. Conclusive results obtained recently in animal models have confirmed the erythropoiesis activity of PBI-1402 even when there is little or no endogenous EPO produced by the kidney.

About PBI-1402

PBI-1402 is an orally active compound being develo
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
2. ProMetic provides business update - Over $35 million worth of business secured in January
3. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
4. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
5. VaxGen Reports Financial Update
6. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
7. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
8. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
9. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
10. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
11. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at BioCentury,s NewsMakers in the Biotech Industry conference ... from the Millennium Broadway Hotel & Conference Center in ... presentation can be accessed at www.meipharma.com . A replay ...
(Date:9/18/2014)... ST. LOUIS , Sept. 18, 2014 /PRNewswire/ ... ) announced today it has entered into a ... Michigan (U-M) Medical School,s Vector Core. Under the ... Sigma CRISPR technology, experimental design consultation, and dedicated ... poised to accelerate gene editing-based research at the ...
(Date:9/18/2014)... Now a team led by an engineer at Michigan ... that will let scientists slash the cost of one ... Syringe pumps are used to dispatch precise amounts of ... a reaction. They can also cost hundreds or even ... of Michigan Tech students published the library of free ...
(Date:9/18/2014)... The quest for the ultimate memory device for computing ... at The City College of New York led by ... exhibit both magnetic and ferroelectric properties. , Combining both ... can occur between them and for the devices that ... Combining these two properties in a single material, however, ...
Breaking Biology Technology:MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4Doing science just got cheaper -- and faster 2Oxides discovered by CCNY team could advance memory devices 2
... few months, 2004 delivered some promising advances in Wisconsin technology. ... has set in motion public initiatives to help entrepreneurs and ... Technology Network just turned two. To celebrate, here are some ... leading CIOs ,Wisconsins CIOs continue to push IT forward ...
... realm of content management systems (CMS) providers, Northwoods ... for clients. Forget the gearhead techno-speak. The Milwaukee area ... issues through plain talk and better Web design. , ... Web, said Pat Bieser, founder and CEO of the ...
... agencies have backed a new organization, the Wisconsin Angel ... , ,Wisconsin excels in researching and developing cutting-edge technology ... first and most critical stage, said Governor ... , ,The Wisconsin Technology Council , which advises ...
Cached Biology Technology:2004 in review: Editors picks 22004 in review: Editors picks 3Untangling the Web: Northwoods Software in profile 2Untangling the Web: Northwoods Software in profile 3Untangling the Web: Northwoods Software in profile 4Untangling the Web: Northwoods Software in profile 5
(Date:9/17/2014)... has received a $260,000 grant from the Andrew W. ... the Human in the Age of the Life Sciences." ... events aimed at exploring two compelling themes in the ... are exploring the boundaries of our self-definition as a ... involves the increasingly influential hypothesis that we are living ...
(Date:9/17/2014)... EC-FP5 four-year project, delivering its first release in 2004. ... in several EC projects, as a part of the ... BON), to increase the general awareness of the work ... dissemination of the Fauna Europaea results, the ... e-Publishing tools to prepare data papers for all 56 ...
(Date:9/17/2014)... cleverly, some lessons on how to create the features ... director of the Optical Technology Center at Montana State ... nanoscale, we,ll discover them." , Some of those lessons ... conference called "The Nature of Light: Light in Nature" ... of Arizona College of Optical Sciences. The conference was ...
Breaking Biology News(10 mins):Mellon Foundation awards grant for major project in the humanities and sciences 2Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3
... of birds reproduce not by rearing their own young, but ... Known as brood parasitism, this habit has been most thoroughly ... the nests of martins and swallows in Europe are rarely ... the Hainan Normal University in China and his colleagues suggests ...
... research team has identified seven new gene loci linked to obesity. ... cause extreme obesity are similar to those that cause milder forms ... people were included in the study of the links between genes ... Nature Genetics . The aim of the study was to ...
... 2013, Cleveland: A compound abundant in red meat and added ... to promote atherosclerosis or the hardening or clogging of ... this week in the journal Nature Medicine . ... digestive tract metabolize the compound carnitine, turning it into trimethylamine-N-oxide ...
Cached Biology News:Birds find ways to avoid raising cuckoos' young 2Genes behind obesity mapped in large-scale study 2Cleveland Clinic researchers discover new link between heart disease and red meat 2Cleveland Clinic researchers discover new link between heart disease and red meat 3
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD69 TAC is designed to deplete human CD69 from samples to isolate resting CD4+ or CD8+ T cells....
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
No-Weigh Dithiothreitol (DTT) ,7.7 mg DTT/Tube x 48 tubes...
Biology Products: